Not applicableUnknownNCT06303635What this trial is testingSafety of UFRJvac, Trivalent COVID-19 VaccineWho this might be right forHealthy People Azidus Brasil 156
Not applicableUnknownNCT05175989What this trial is testingSARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19Who this might be right forCOVID-19 Vaccine Rabin Medical Center 150
Large-scale testing (Phase 3)Study completedNCT04887948What this trial is testingSafety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2Who this might be right forPneumococcal DiseaseCOVID-19SARS-CoV-2 Infection Pfizer 570
Large-scale testing (Phase 3)UnknownNCT04536051What this trial is testingA Candidate COVID-19 Vaccine (COV003)Who this might be right forCoronavirus University of Oxford 10,300
Testing effectiveness (Phase 2)Study completedNCT05576623What this trial is testingSafety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive VaccineWho this might be right forCOVID-19Vaccines Cellid Co., Ltd. 320
Post-approval studies (Phase 4)Study completedNCT05080218What this trial is testingCOVID-19 VaccinE Response in Rheumatology PatientsWho this might be right forRheumatoid ArthritisPsoriatic ArthritisSpondylarthritis Jeffrey Curtis 841
Testing effectiveness (Phase 2)Study completedNCT05205096What this trial is testingImmunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVacWho this might be right forCOVID-19 Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Not applicableStudy completedNCT05054218What this trial is testingCOVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer PatientsWho this might be right forCovid19SARS-CoV2 Infection H. Lee Moffitt Cancer Center and Research Institute 336
Not applicableEnded earlyNCT05142540What this trial is testingDetection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster VaccinesWho this might be right forAnti-SARS-CoV-2 Antibody Response Medical University of Graz 140
Testing effectiveness (Phase 2)Study completedNCT04847050What this trial is testingA Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor TherapyWho this might be right forSolid Tumor MalignancyHematologic MalignancyLeukemia+2 more National Cancer Institute (NCI) 19
Not applicableEnded earlyNCT05252910What this trial is testingSpecimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and AdolescentsWho this might be right forCOVID-19 Pharm-Olam, LLC 33
Not applicableStudy completedNCT04830046What this trial is testingCovid-19 Vaccine Responsiveness in MM and WaldenstromWho this might be right forMultiple MyelomaWaldenstrom MacroglobulinemiaImmune System Disorder+1 more Massachusetts General Hospital 146
Not applicableStudy completedNCT05164016What this trial is testingEvaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy RecipientsWho this might be right forCancerHematopoietic System--CancerTransplant-Related Cancer+5 more St. Jude Children's Research Hospital 21
Not applicableStudy completedNCT06646744What this trial is testingSafety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)Who this might be right forCOVID-19 Vaccine Adverse Reaction Ana Belen Rivas Paterna 2,100
Testing effectiveness (Phase 2)UnknownNCT04954131What this trial is testingImmunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin ChinaWho this might be right forCOVID-19 Zhejiang Clover Biopharmaceuticals, Inc. 766
Not applicableUnknownNCT04391400What this trial is testingThe Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or VaccinesWho this might be right forSARS-CoV-2 Invivoscribe, Inc. 500
Not applicableStudy completedNCT05252936What this trial is testingEffectiveness of a Mayan Language Social Media Campaign on COVID-19 Vaccine Beliefs in GuatemalaWho this might be right forVaccination Refusal Stanford University 5,000
Early research (Phase 1)UnknownNCT05047445What this trial is testingA First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free InjectionWho this might be right forCOVID-19 Scancell Ltd 80
Not applicableEnded earlyNCT04870411What this trial is testingImmunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or BiologicsWho this might be right forAutoimmune DiseasesInflammatory Disorder Assistance Publique - Hôpitaux de Paris 78
Early research (Phase 1)Study completedNCT04895449What this trial is testingSafety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19Who this might be right forCovid19 Universitätsklinikum Hamburg-Eppendorf 43